{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:15:59Z","timestamp":1783692959421,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Tibet Fund"},{"name":"Friends of the Delek Hospital"},{"name":"Pittsfield Anti-Tuberculosis Association"},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tuberculosis (TB) prevalence is high among Tibetan refugees in India, with almost half of cases occurring in congregate facilities, including schools. A comprehensive program of TB case finding and treatment of TB infection (TBI) was undertaken in schools for Tibetan refugee children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Schoolchildren and staff in Tibetan schools in Himachal Pradesh, India, were screened for TB with an algorithm using symptoms, chest radiography, molecular diagnostics, and tuberculin skin testing. Individuals with active TB were treated and those with TBI were offered isoniazid-rifampicin preventive therapy for 3 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From April 2017 to March 2018, we screened 5391 schoolchildren (median age, 13 years) and 786 staff in 11 Tibetan schools. Forty-six TB cases, including 1 with multidrug resistance, were found in schoolchildren, for a prevalence of 853 per 100 000. Extensively drug-resistant TB was diagnosed in 1 staff member. The majority of cases (66%) were subclinical. TBI was detected in 930 of 5234 (18%) schoolchildren and 334 of 634 (53%) staff who completed testing. Children in boarding schools had a higher prevalence of TBI than children in day schools (915\/5020 [18%] vs 15\/371 [4%]; P &lt; .01). Preventive therapy was provided to 799 of 888 (90%) schoolchildren and 101 of 332 (30%) staff with TBI; 857 (95%) people successfully completed therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>TB prevalence is extremely high among Tibetan schoolchildren. Effective active case finding and a high uptake and completion of preventive therapy for children were achieved. With leadership and community mobilization, TB control is implementable on a population level.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciy987","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T21:08:28Z","timestamp":1542402508000},"page":"760-768","source":"Crossref","is-referenced-by-count":31,"title":["High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children"],"prefix":"10.1093","volume":"69","author":[{"given":"Kunchok","family":"Dorjee","sequence":"first","affiliation":[{"name":"Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Topgyal","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungdak","family":"Dorjee","sequence":"additional","affiliation":[{"name":"Tibetan Children\u2019s Village School, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Tsundue","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Namdol","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Tsewang","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Nangsel","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekyi","family":"Lhadon","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsering","family":"Choetso","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Dawa","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin","family":"Phentok","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea N","family":"DeLuca","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobsang","family":"Tsering","sequence":"additional","affiliation":[{"name":"Department of Health, Central Tibetan Administration, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawa","family":"Phunkyi","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsetan D","family":"Sadutshang","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis, Tibetan Delek Hospital, Dharamsala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"J Bonomo","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorba","family":"Paster","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin\u2013Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"2019081601550913700_CIT0001","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(14)60195-1","article-title":"Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates","volume":"383","author":"Jenkins","year":"2014","journal-title":"Lancet"},{"key":"2019081601550913700_CIT0002","volume-title":"WHO global tuberculosis report 2017","year":"2017"},{"key":"2019081601550913700_CIT0003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(16)30474-1","article-title":"Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis","volume":"17","author":"Jenkins","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019081601550913700_CIT0004","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0277-9536(01)00041-7","article-title":"Tuberculosis among Tibetan refugees in India","volume":"54","author":"Bhatia","year":"2002","journal-title":"Soc Sci Med"},{"key":"2019081601550913700_CIT0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3201\/eid2203.140732","article-title":"Improved detection of tuberculosis and multidrug-resistant tuberculosis among Tibetan refugees, India","volume":"22","author":"Dierberg","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2019081601550913700_CIT0006","first-page":"1018","article-title":"Population-based risk factors for tuberculosis and adverse outcomes among Tibetan refugees in India, 1994-1996","volume":"9","author":"Nelson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019081601550913700_CIT0007","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5588\/ijtld.13.0516","article-title":"Survey of tuberculosis drug resistance among Tibetan refugees in India","volume":"18","author":"Salvo","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019081601550913700_CIT0008","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1012223510638","article-title":"Rising number of tuberculosis cases among Tibetans in New York City","volume":"3","author":"Lee","year":"2001","journal-title":"J Immigr Health"},{"key":"2019081601550913700_CIT0009","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1378\/chest.124.3.915","article-title":"Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000","volume":"124","author":"Marras","year":"2003","journal-title":"Chest"},{"key":"2019081601550913700_CIT0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jama.1997.03540330057035","article-title":"Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992-1995","volume":"277","author":"Truong","year":"1997","journal-title":"JAMA"},{"key":"2019081601550913700_CIT0011","year":"2017"},{"key":"2019081601550913700_CIT0012","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"2019081601550913700_CIT0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S2213-2600(15)00095-8","article-title":"Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis","volume":"3","author":"Detjen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2019081601550913700_CIT0014","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(14)70245-1","article-title":"Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study","volume":"2","author":"Dodd","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2019081601550913700_CIT0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(14)71085-0","article-title":"Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study","volume":"15","author":"Gao","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2019081601550913700_CIT0016","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1183\/13993003.00893-2016","article-title":"Progression to tuberculosis disease increases with multiple exposures","volume":"48","author":"Lee","year":"2016","journal-title":"Eur Respir J"},{"key":"2019081601550913700_CIT0017","first-page":"278","article-title":"The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019081601550913700_CIT0018","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019081601550913700_CIT0019","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019081601550913700_CIT0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"key":"2019081601550913700_CIT0021","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1365-3156.2012.03053.x","article-title":"Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions","volume":"17","author":"Rutherford","year":"2012","journal-title":"Trop Med Int Health"},{"key":"2019081601550913700_CIT0022","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/520983","article-title":"The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study","volume":"45","author":"Spyridis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019081601550913700_CIT0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2019081601550913700_CIT0024","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2019081601550913700_CIT0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/thx.2009.125054","article-title":"Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB","volume":"65","author":"Aspler","year":"2010","journal-title":"Thorax"},{"key":"2019081601550913700_CIT0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"2019081601550913700_CIT0027","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"Page","year":"2006","journal-title":"Arch Intern Med"},{"key":"2019081601550913700_CIT0028","first-page":"13","article-title":"Adherence to anti-tuberculosis chemoprophylaxis and treatment in children","volume":"10","author":"van Zyl","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019081601550913700_CIT0029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2334-14-91","article-title":"Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis","volume":"14","author":"Ayieko","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2019081601550913700_CIT0030","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2019081601550913700_CIT0031","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection","volume":"386","author":"Rangaka","year":"2015","journal-title":"Lancet"},{"key":"2019081601550913700_CIT0032"},{"key":"2019081601550913700_CIT0033","volume-title":"The End TB Strategy","year":"2015"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/5\/760\/29169426\/ciy987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T08:42:05Z","timestamp":1568968925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/5\/760\/5193441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,11,20]]},"published-print":{"date-parts":[[2019,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy987","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9,1]]},"published":{"date-parts":[[2018,11,20]]}}}